Literature DB >> 20456938

The inherited genetics of ovarian and endometrial cancer.

Simon A Gayther1, Paul D P Pharoah.   

Abstract

Endometrial and epithelial ovarian cancers are the fourth and fifth most common cancers in women in developed countries, after breast, lung, and colorectal cancer. In the United States alone, in 2008 there were about 40,000 new diagnoses of endometrial cancer and 7500 disease-related deaths. For ovarian cancer, there were about 22,000 new diagnoses and 15,000 deaths over the same period. The purpose of this article is to review the recent developments in the inherited genetics of ovarian and endometrial cancer, with particular attention to recent progress in identifying common low-penetrance susceptibility genes and their clinical implications.

Entities:  

Mesh:

Year:  2010        PMID: 20456938      PMCID: PMC3073171          DOI: 10.1016/j.gde.2010.03.001

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  55 in total

1.  Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study.

Authors:  F Parazzini; E Negri; C La Vecchia; C Restelli; S Franceschi
Journal:  Am J Epidemiol       Date:  1992-01-01       Impact factor: 4.897

2.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

3.  Evaluation of germline PTEN mutations in endometrial cancer patients.

Authors:  Destin Black; Faina Bogomolniy; Mark E Robson; Kenneth Offit; Richard R Barakat; Jeff Boyd
Journal:  Gynecol Oncol       Date:  2005-01       Impact factor: 5.482

Review 4.  Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.

Authors:  Larissa A Meyer; Russell R Broaddus; Karen H Lu
Journal:  Cancer Control       Date:  2009-01       Impact factor: 3.302

5.  Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Authors:  Usha Menon; Aleksandra Gentry-Maharaj; Rachel Hallett; Andy Ryan; Matthew Burnell; Aarti Sharma; Sara Lewis; Susan Davies; Susan Philpott; Alberto Lopes; Keith Godfrey; David Oram; Jonathan Herod; Karin Williamson; Mourad W Seif; Ian Scott; Tim Mould; Robert Woolas; John Murdoch; Stephen Dobbs; Nazar N Amso; Simon Leeson; Derek Cruickshank; Alistair McGuire; Stuart Campbell; Lesley Fallowfield; Naveena Singh; Anne Dawnay; Steven J Skates; Mahesh Parmar; Ian Jacobs
Journal:  Lancet Oncol       Date:  2009-03-11       Impact factor: 41.316

Review 6.  Role of genetic polymorphisms and ovarian cancer susceptibility.

Authors:  Peter A Fasching; Simon Gayther; Leigh Pearce; Joellen M Schildkraut; Ellen Goode; Falk Thiel; Georgia Chenevix-Trench; Jenny Chang-Claude; Shan Wang-Gohrke; Susan Ramus; Paul Pharoah; Andrew Berchuck
Journal:  Mol Oncol       Date:  2009-02-04       Impact factor: 6.603

7.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

Authors:  H F Vasen; J T Wijnen; F H Menko; J H Kleibeuker; B G Taal; G Griffioen; F M Nagengast; E H Meijers-Heijboer; L Bertario; L Varesco; M L Bisgaard; J Mohr; R Fodde; P M Khan
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

8.  Genome-wide association studies in cancer.

Authors:  Douglas F Easton; Rosalind A Eeles
Journal:  Hum Mol Genet       Date:  2008-10-15       Impact factor: 6.150

9.  Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.

Authors:  Sunil R Lakhani; Sanjiv Manek; Frederique Penault-Llorca; Adrienne Flanagan; Laurent Arnout; Samantha Merrett; Lesley McGuffog; Dawn Steele; Peter Devilee; Jan G M Klijn; Hanne Meijers-Heijboer; Paolo Radice; Silvana Pilotti; Heli Nevanlinna; Ralf Butzow; Hagay Sobol; Jocylyne Jacquemier; Dominique Stoppa Lyonet; Susan L Neuhausen; Barbara Weber; Teresa Wagner; Robert Winqvist; Yves-Jean Bignon; Franco Monti; Fernando Schmitt; Gilbert Lenoir; Susanne Seitz; Ute Hamman; Paul Pharoah; Geoff Lane; Bruce Ponder; D Timothy Bishop; Douglas F Easton
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

10.  Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.

Authors:  C L Pearce; A H Wu; S A Gayther; A E Bale; P A Beck; J Beesley; S Chanock; D W Cramer; R DiCioccio; R Edwards; Z S Fredericksen; M Garcia-Closas; E L Goode; A C Green; L C Hartmann; E Hogdall; S K Kjaer; J Lissowska; V McGuire; F Modugno; K Moysich; R B Ness; S J Ramus; H A Risch; T A Sellers; H Song; D O Stram; K L Terry; P M Webb; D C Whiteman; A S Whittemore; W Zheng; P D P Pharoah; G Chenevix-Trench; M C Pike; J Schildkraut; A Berchuck
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

View more
  25 in total

Review 1.  [Hereditary breast and ovarian cancer].

Authors:  S F Lax
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

2.  Gynecologic cancer mortality in Trinidad and Tobago and comparisons of mortality-to-incidence rate ratios across global regions.

Authors:  Adana A M Llanos; Wayne A Warner; Silvana Luciani; Tammy Y Lee; Smriti Bajracharya; Simeon Slovacek; Veronica Roach; Marjorie Lamont-Greene
Journal:  Cancer Causes Control       Date:  2017-09-15       Impact factor: 2.506

Review 3.  Epigenetics in ovarian cancer.

Authors:  Yanina Natanzon; Ellen L Goode; Julie M Cunningham
Journal:  Semin Cancer Biol       Date:  2017-08-03       Impact factor: 15.707

4.  KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer.

Authors:  Elisa Caiola; Eliana Rulli; Robert Fruscio; Alessandro Buda; Massimo Broggini; Mirko Marabese
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

5.  Mainstreaming genetic testing of cancer predisposition genes.

Authors:  Nazneen Rahman
Journal:  Clin Med (Lond)       Date:  2014-08       Impact factor: 2.659

6.  Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk.

Authors:  Min Li; Yuan-Yue Li; Xiao-Yan Xin; Ying Han; Ting-Ting Wu; Hong-Bo Wang
Journal:  Tumour Biol       Date:  2013-07-17

Review 7.  DNA methylation changes in epithelial ovarian cancer histotypes.

Authors:  Madalene A Earp; Julie M Cunningham
Journal:  Genomics       Date:  2015-09-10       Impact factor: 5.736

8.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.

Authors:  Paul D P Pharoah; Rachel T Palmieri; Susan J Ramus; Simon A Gayther; Irene L Andrulis; Hoda Anton-Culver; Natalia Antonenkova; Antonis C Antoniou; David Goldgar; Mary S Beattie; Matthias W Beckmann; Michael J Birrer; Natalia Bogdanova; Kelly L Bolton; Wendy Brewster; Angela Brooks-Wilson; Robert Brown; Ralf Butzow; Trinidad Caldes; Maria Adelaide Caligo; Ian Campbell; Jenny Chang-Claude; Y Ann Chen; Linda S Cook; Fergus J Couch; Daniel W Cramer; Julie M Cunningham; Evelyn Despierre; Jennifer A Doherty; Thilo Dörk; Matthias Dürst; Diana M Eccles; Arif B Ekici; Douglas Easton; Peter A Fasching; Anna de Fazio; David A Fenstermacher; James M Flanagan; Brooke L Fridley; Eitan Friedman; Bo Gao; Olga Sinilnikova; Aleksandra Gentry-Maharaj; Andrew K Godwin; Ellen L Goode; Marc T Goodman; Jenny Gross; Thomas V O Hansen; Paul Harnett; Matti Rookus; Tuomas Heikkinen; Rebecca Hein; Claus Høgdall; Estrid Høgdall; Edwin S Iversen; Anna Jakubowska; Sharon E Johnatty; Beth Y Karlan; Noah D Kauff; Stanley B Kaye; Georgia Chenevix-Trench; Linda E Kelemen; Lambertus A Kiemeney; Susanne Krüger Kjaer; Diether Lambrechts; James P Lapolla; Conxi Lázaro; Nhu D Le; Arto Leminen; Karin Leunen; Douglas A Levine; Yi Lu; Lene Lundvall; Stuart Macgregor; Tamara Marees; Leon F Massuger; John R McLaughlin; Usha Menon; Marco Montagna; Kirsten B Moysich; Steven A Narod; Katherine L Nathanson; Lotte Nedergaard; Roberta B Ness; Heli Nevanlinna; Stefan Nickels; Ana Osorio; Jim Paul; Celeste Leigh Pearce; Catherine M Phelan; Malcolm C Pike; Paolo Radice; Mary Anne Rossing; Joellen M Schildkraut; Thomas A Sellers; Christian F Singer; Honglin Song; Daniel O Stram; Rebecca Sutphen; Annika Lindblom; Kathryn L Terry; Ya-Yu Tsai; Anne M van Altena; Ignace Vergote; Robert A Vierkant; Allison F Vitonis; Christine Walsh; Shan Wang-Gohrke; Barbara Wappenschmidt; Anna H Wu; Argyrios Ziogas; Andrew Berchuck; Harvey A Risch
Journal:  Clin Cancer Res       Date:  2011-03-08       Impact factor: 12.531

Review 9.  Realizing the promise of cancer predisposition genes.

Authors:  Nazneen Rahman
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

10.  Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.

Authors:  Madalene A Earp; Linda E Kelemen; Anthony M Magliocco; Kenneth D Swenerton; Georgia Chenevix-Trench; Yi Lu; Alexander Hein; Arif B Ekici; Matthias W Beckmann; Peter A Fasching; Diether Lambrechts; Evelyn Despierre; Ignace Vergote; Sandrina Lambrechts; Jennifer A Doherty; Mary Anne Rossing; Jenny Chang-Claude; Anja Rudolph; Grace Friel; Kirsten B Moysich; Kunle Odunsi; Lara Sucheston-Campbell; Galina Lurie; Marc T Goodman; Michael E Carney; Pamela J Thompson; Ingo B Runnebaum; Matthias Dürst; Peter Hillemanns; Thilo Dörk; Natalia Antonenkova; Natalia Bogdanova; Arto Leminen; Heli Nevanlinna; Liisa M Pelttari; Ralf Butzow; Clareann H Bunker; Francesmary Modugno; Robert P Edwards; Roberta B Ness; Andreas du Bois; Florian Heitz; Ira Schwaab; Philipp Harter; Beth Y Karlan; Christine Walsh; Jenny Lester; Allan Jensen; Susanne K Kjær; Claus K Høgdall; Estrid Høgdall; Lene Lundvall; Thomas A Sellers; Brooke L Fridley; Ellen L Goode; Julie M Cunningham; Robert A Vierkant; Graham G Giles; Laura Baglietto; Gianluca Severi; Melissa C Southey; Dong Liang; Xifeng Wu; Karen Lu; Michelle A T Hildebrandt; Douglas A Levine; Maria Bisogna; Joellen M Schildkraut; Edwin S Iversen; Rachel Palmieri Weber; Andrew Berchuck; Daniel W Cramer; Kathryn L Terry; Elizabeth M Poole; Shelley S Tworoger; Elisa V Bandera; Urmila Chandran; Irene Orlow; Sara H Olson; Elisabeth Wik; Helga B Salvesen; Line Bjorge; Mari K Halle; Anne M van Altena; Katja K H Aben; Lambertus A Kiemeney; Leon F A G Massuger; Tanja Pejovic; Yukie T Bean; Cezary Cybulski; Jacek Gronwald; Jan Lubinski; Nicolas Wentzensen; Louise A Brinton; Jolanta Lissowska; Montserrat Garcia-Closas; Ed Dicks; Joe Dennis; Douglas F Easton; Honglin Song; Jonathan P Tyrer; Paul D P Pharoah; Diana Eccles; Ian G Campbell; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Joseph H Rothstein; James M Flanagan; James Paul; Robert Brown; Catherine M Phelan; Harvey A Risch; John R McLaughlin; Steven A Narod; Argyrios Ziogas; Hoda Anton-Culver; Aleksandra Gentry-Maharaj; Usha Menon; Simon A Gayther; Susan J Ramus; Anna H Wu; Celeste L Pearce; Malcolm C Pike; Agnieszka Dansonka-Mieszkowska; Iwona K Rzepecka; Lukasz M Szafron; Jolanta Kupryjanczyk; Linda S Cook; Nhu D Le; Angela Brooks-Wilson
Journal:  Hum Genet       Date:  2013-11-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.